Eukaryotic translation can be initiated either by a capdependent mechanism or by internal ribosome entry, a process by which ribosomes are directly recruited to structured regions of mRNA upstream of the initiation codon. We analysed the 5' untranslated region (UTR) of the proto-oncogene N-myc, and demonstrated by transfections in a dicistronic vector system that it contains a potent internal ribosome entry segment (IRES). The IRES is similar in length to the c-myc IRES and the activities of these IRESs are comparable in non-neuronal cells. Transfections were also carried out in cell lines derived from neuroblastomas, in which Nmyc is expressed, and in a neuronal precursor cell line. In these cells the N-myc IRES is up to seven times more active than that of c-myc, suggesting that neuronalspeci®c non-canonical trans-acting factors are used by the N-myc but not the c-myc IRES. N-myc expression is increased by gene ampli®cation in many neuroblastomas, but this is the ®rst example of a translational mechanism by which N-myc expression could be further increased. The discovery of an IRES that displays enhanced activity in neuronal cell lines has important potential as a tool for protein expression in neural tissue. Oncogene (2001) 20, 2664 ± 2670.
Introduction
The myc family of genes comprises c-, N-, and L-myc. All three genes give rise to nuclear phosphoproteins that function as transcription factors. The Myc proteins are known to perform this role by binding to target E-box DNA sequences as heterodimers with the protein Max (Blackwood and Eisenman, 1991; Dang, 1999) . Myc proteins are important in the control of cell growth, dierentiation, and apoptosis (Lutz et al., 1996 (Lutz et al., , 1998 Dang, 1999) , although the identity of Myc target genes has proved to be elusive. In accordance with the stimulatory eect of the Myc proteins on cell growth, their overexpression is associated with a number of dierent cancers. N-myc was originally identi®ed as a gene ampli®ed in neuroblastoma (Schwab et al., 1983) and further work has shown that overexpression of N-myc occurs in almost all neuroblastomas; high levels of N-Myc correlate with a poor prognosis (Brodeur et al., 1984) . N-myc overexpression has also been documented in some small cell lung carcinomas and occasionally in other tumours (Nesbit et al., 1999) .
The physiological expression of N-myc is restricted to early stages of development. For example, during embryogenesis N-myc is expressed in the gut, kidney and lung, and at highest levels in the central nervous system (Zimmerman et al., 1986) . Knockout studies show that N-Myc is essential for embryonic survival (Stanton et al., 1992 ) and a recent study has shown that the N-myc gene can functionally replace c-myc in transgenic mice (Malynn et al., 2000) . C-myc has a dierent expression pattern to that of N-myc and is almost ubiquitous. However, the organization of the N-myc gene is very similar to that of c-myc, comprising three exons, exon 1 of which is entirely non-coding . Hence, both genes give rise to mRNAs that have long 5' untranslated regions (UTR) with a high degree of predicted secondary structure. The c-myc 5' UTR is involved in translational regulation (Saito et al., 1983) and recently we and others have shown that the 5' UTR of the c-myc mRNA contains an internal ribosome entry segment (IRES) (Stoneley et al., 1998; Nanbru et al., 1997) .
IRESs are highly structured regions of RNA that are able to recruit the 40S subunit independently of a cap structure and, in most cases, in the absence of intact eukaryotic initiation factor 4G (eIF4G) (Jackson et al., 1995; Stoneley et al., 2000a) . IRESs were ®rst identi®ed in the picornaviral family but a number of cellular IRESs have been identi®ed. A high proportion of cellular IRESs have been located in genes involved in cell growth or death, for example ®broblast growth factor-2 (FGF-2) (Vagner et al., 1995) , vascular endothelial growth factor (Akiri et al., 1998; Huez et al., 1998; Miller et al., 1998; Stein et al., 1998) , platelet derived growth factor (PDGF) (Bernstein et al., 1997) , the apoptotic protease activating factor-1 (Coldwell et al., 2000) , the X-linked inhibitor of apoptosis (Holcik et al., 1999) , and death-associated protein 5 (Henis- Korenblit et al., 2000) . It is becoming apparent that certain cellular IRESs are utilised during physiological situations in which cap-dependent translation is reduced. For example, c-myc IRES-dependent translation is maintained during apoptosis when eIF4G is cleaved by caspases (Stoneley et al., 2000a) , while the PDGF and AML1 IRESs are induced during cellular dierentiation (Bernstein et al., 1997; Pozner et al., 2000) and ornithine decarboxylase and the p58 PITSLRE protein kinase possess IRESs that function during mitosis (Pyronnet et al., 2000; Cornelis et al., 2000) . There is very little sequence similarity between the cmyc and N-myc 5' UTRs, but as the N-myc 5' UTR is long and GC-rich, with a high degree of predicted secondary structure, we decided to investigate the possibility that N-myc could contain an IRES.
Results
The published N-myc 5' UTR sequence contains an incorrectly assigned splice site
To investigate whether the N-myc 5' UTR is translationally regulated, we obtained the DNA corresponding to this region by RT ± PCR of RNA from ®ve human neuroblastoma-derived cell lines. The PCR products were all 327 bp in size, whereas the predicted size was 637 bp (Ibson and Rabbitts, 1988) . Sequencing indicated that the size disparity was due to the incorrect prediction of the position of the donor splice site of intron 1. No larger PCR product compatible with the published splice site was detected, con®rming that the exon1/intron 1 boundary is upstream of the published position, and the donor splice site we obtained is in good context. Furthermore, the murine (Katoh et al., 1988) and rat (Sugiyama et al., 1991) N-myc 5' UTRs are similar in length to that obtained from human cells and show high levels of homology (74.2 and 77.7% identical, respectively) with exon 1/intron 1 boundaries in a similar position.
The N-myc 5' UTR contains an internal ribosome entry segment
The cDNA encoding the human N-myc 5' UTR was inserted into the dicistronic vector pRF (Figure 1a ; previously known as pGL3R2, Stoneley et al., 1998) to create the construct pRNF. This was transfected into HeLa cells in parallel with pRF, pRMF and pRemcvF (in which the c-myc and EMCV IRESs have been inserted between the two cistrons of pRF). The activities of Renilla and ®re¯y luciferases were determined and normalized to a transfection control of b-galactosidase. Translation of the upstream Renilla luciferase cistron is cap-dependent, whereas the downstream ®re¯y luciferase cistron is translated at a very low rate unless internal ribosome entry can occur between the two cistrons. In HeLa cells the N-myc 5' UTR was seen to stimulate downstream cistron expression to a considerable extent (87-fold) relative to that seen in the control vector (Figure 1b ). This suggests that the N-myc 5' UTR contains an element capable of stimulating internal ribosome entry. The stimulation of downstream cistron expression observed is approximately threefold greater than that seen with the highly active EMCV IRES, and marginally higher than that seen with the c-myc IRES (Figure 1b) .
To ensure that internal ribosome entry rather than enhanced ribosomal readthrough or reinitiation was responsible for the stimulation observed, the DNA encoding the N-myc 5' UTR was inserted into the vector phpRF to create the construct phpRNF ( Figure  2a ). This harbours a palindromic sequence upstream of the Renilla luciferase coding region that, when transcribed, forms a stable RNA hairpin (755 kcal/ mol). This is sucient to impede scanning ribosomes, leading to an 80% reduction in expression of the capdependent Renilla luciferase cistron on transfection into NB2a cells. Expression of ®re¯y luciferase induced by the N-myc 5' UTR did not show a concomitant decrease in the presence of the hairpin (Figure 2b ). The small induction seen is likely to be due to the increased availability of limiting initiation factors when translation of Renilla luciferase is reduced. This demonstrates that the N-myc 5' UTR does not induce downstream cistron activity by a stimulation of ribosomal readthrough or reinitiation.
It is possible that a cryptic promoter or splice site or an RNA cleavage site is present in the N-myc 5' UTR, Oncogene N-myc contains a neuronal-enhanced IRES CL Jopling and AE Willis leading to the production of monocistronic mRNAs from which ®re¯y luciferase can be expressed on transfection of pRNF. RNase protection assays were carried out using RNA extracted from HeLa cells 48 h after transient transfection with pRNF. This RNA was hybridized to a radiolabelled probe complementary to a region of pRNF encompassing the 3' end of the Renilla luciferase cistron, the N-myc 5' UTR, and the 5' end of the ®re¯y luciferase cistron (Figure 2c) . A band of the expected size for a full length dicistronic RNA was protected from RNase one digestion (Figure 2d , lane 3). If a monocistronic ®re¯y luciferase RNA were present, to be functional it would have to be at least 101 nucleotides in length. No bands of this size were detected. No protected products were detected when RNA was extracted from mock-transfected HeLa cells (Figure 2d, lane 2) . The N-myc 5' UTR is therefore able to stimulate expression of the downstream cistron in the context of a dicistronic RNA, and we conclude that it contains an IRES.
The N-myc IRES has enhanced activity in neuronal cell types
The N-myc IRES was compared to the c-myc IRES by transfection of pRNF into various cell lines in parallel with the vector pRMF (previously known as pGL3R2utr, Stoneley et al., 1998) , which harbours the c-myc 5' UTR. The activities of Renilla and ®re¯y luciferases were calculated and IRES activity in each cell line was determined by the ratio of ®re¯y:Renilla (Figure 3 ). The ratio of N-myc:c-myc IRES activity for each cell line is indicated in a table (Figure 3) . We observed that in the cell lines HeLa and MCF7, which The neuronal precursor cell line NT2, the neuroblastoma cell lines NB2a and SH-SY5Y, and the embryonic kidney cell line HEK293 were also transfected. In all these cell lines the N-myc IRES induced downstream cistron expression to a much greater extent than c-myc, with a maximum relative activation of 6.83-fold seen in the human neuroblastoma cell line SH-SY5Y. It therefore appears that the Nmyc IRES is speci®cally activated relative to that of cmyc in cells in which N-myc is expressed. Both the hairpin vector and RNase protection control experiments were carried out in neuronal cell types with the same results as in HeLa cells (data not shown). We observe no correlation between the absolute activity of the N-myc IRES as determined by ®re¯y:Renilla ratios and its activity relative to the c-myc IRES (Figure 3) in the dierent cell lines tested.
The complete N-myc IRES is necessary for full activity
To map the N-myc IRES in greater detail a deletion series was constructed. Fragments of approximately 80 nucleotides in length were deleted sequentially from both the 5' and 3' ends of the N-myc 5' UTR and the truncated products obtained were inserted into the vector pRF between the Renilla and ®re¯y luciferase cistrons. The resultant plasmids were analysed by transfection into HeLa, NB2a and NT2 cells. Renilla and ®re¯y luciferase activities were determined and the ratio of ®re¯y:Renilla was compared to that obtained from the parent vector pRNF (Figure 4) . The deletions had similar eects in all three cell lines. A 50 ± 60% decrease in IRES activity was observed on deletion of the most 5' 86 nucleotides, although deletion of the next 70 nucleotides had no further eect. However, further deletion of 85 nucleotides from the 5' end led to an almost complete abolition of IRES activity, with a reduction to 3 ± 10% of full activity. All deletions from the 3' end of the IRES had a drastic eect on IRES activity, with reductions of 80 ± 90%, 88 ± 96% and 96 ± 98% observed on deletion of 74, 159 and 229 nucleotides respectively. These data imply that the entire 5' UTR is necessary for full IRES activity and that the 3' end in particular is crucial.
N-myc IRES activity decreases during neuronal differentiation
It is known that the expression of N-myc decreases during the dierentiation of neuronal cells (Thiele et al., 1985) . We therefore examined the behaviour of the N-myc IRES during this process in three dierent cell lines, NB2a, NT2, and SH-SY5Y. NB2a and SH-SY5Y cells were subjected to a 24-h induction of dierentiation following transfection with pRNF, using the agents dibutyryl cyclic AMP (dibutyryl cAMP) (Shea, 1994) and retinoic acid (RA) (Strickland and Mahdavi, 1978) respectively. NT2 cells were subjected to a 5-week period of dierentiation induced by RA before transfection with pRNF. Renilla and ®re¯y luciferase activities were determined and normalized to bgalactosidase. In all cells tested the induction of dierentiation caused a decrease in the activity of the N-myc IRES ( Figure 5) . A small decrease in c-myc IRES activity was also seen in cells subjected to the same conditions (data not shown), but the decrease observed for N-myc was much greater. 
Discussion
In conclusion, the N-myc 5' UTR contains a highly active IRES. It is of similar size to that of c-myc and these IRESs share certain other features. Both show comparable activity in non-neuronal cell types and both are inactive in in vitro reticulocyte lysate translation systems (data not shown), implying the need for non-canonical trans-acting factors for activity (Stoneley et al., 2000b) . However, there is very little sequence homology between the c-myc and N-myc IRESs, and the enhanced activity of the N-myc IRES in neuronal cell types suggests a dierential requirement for trans-acting protein factors. This is further supported by the fact that truncation of the N-myc IRES has a far more dramatic eect than that of the cmyc IRES, in which deletions from either the 5' or 3' ends lead to a gradual loss of activity and the most 3' 56 nucleotides can be removed with no reduction of activity (Stoneley et al., 1998) . We posit that the eect of deletions of the N-myc IRES is due to a requirement for the complete UTR to fold into an appropriate secondary structure for the binding of factors necessary for internal ribosome entry. The deletion mutants had the same eect in all cell lines tested, indicating that this is not a neuronal-speci®c observation. We were therefore unable to map the disparity between c-myc and N-myc IRES activity to a particular region of the N-myc IRES.
It is probable that a factor, or factors, present in neuronal precursor cells is able to speci®cally activate the N-myc IRES but has no eect on that of c-myc. Alternatively, factors present only in non-neuronal cells may inhibit the N-myc, but not the c-myc IRES. It was recently shown that a factor that is not expressed in neuronal cells, ITAF 45 , is required for the activity of the foot-and-mouth disease virus (FMDV) IRES, but is not needed by the Theiler's murine encephalomyelitis virus (TMEV) IRES, thereby allowing neurovirulence of TMEV but not FMDV (Pilipenko et al., 2000) . It is possible that a similar mechanism could contribute to the activity of the cmyc and N-myc IRESs, and protein factor requirements will now be investigated.
The reduction of IRES activity during neuronal dierentiation implies that levels of an activating factor are reduced during this process. This observation is in contrast to the IRESs that have previously been shown to be implicated in dierentiation, PDGF and AML1. Both these IRESs are activated during haematopoietic dierentiation (Bernstein et al., 1997; Pozner et al., 2000) . However, in both cases the protein produced by the IRES is upregulated during this dierentiation programme. In addition, the FGF-2 IRES was shown Figure 5 N-myc IRES activity decreases during dierentiation of neuronal cells. The cell lines NB2a and SH-SY5Y were transfected with pRNF and treated with 1 mM dibutyryl cAMP and 4 mM retinoic acid respectively for 24 h prior to harvesting. NT2 cells were subjected to a 5-week period of 10 mM retinoic acid treatment before transfection with pRNF. Renilla (shaded) and ®re¯y (black) luciferase activities are expressed relative to a bgalactosidase control and normalized to the activities obtained on transfection of pRNF into untreated cells of the same type. The results represent an average of three independent experiments Figure 4 The entire N-myc IRES is necessary for full activity. The truncated versions of the N-myc 5' UTR indicated were inserted into the vector pRF and compared to the full UTR by transfection into HeLa (black), NB2a (white) and NT2 (grey) cells. Fire¯y luciferase activity relative to Renilla luciferase activity was calculated for each deletion mutant and is shown as a percentage of full IRES activity. The results represent an average of three independent experiments to be active in brain tissue in transgenic mice as well as in neuroblastoma cells (CreÂ ancier et al., 2000) . For Nmyc the IRES would provide an attractive means of maintaining high protein levels in undierentiated neuronal cells but reducing these levels during dierentiation. The activity of the N-myc IRES did not decline to a level comparable to that of c-myc during the dierentiation processes initiated (data not shown). Even so, the decline in IRES activity we observed during dierentiation is great enough to make a partial contribution to the abolition of N-myc expression in dierentiated neurons.
The expression of N-myc has previously been shown to be regulated at a post-transcriptional level by the binding of a neuronal RNA stabilizing factor to elements in the 3' UTR (Chagnovich and Cohn, 1996) , and by the presence of a tissue-speci®c element that is inhibitory to gene expression in intron 1 (Sivak et al., 1999) . We have identi®ed a method by which the translation of N-myc RNA is regulated in a neuronalspeci®c manner, thereby emphasising the complexity of the control of N-myc expression in neuronal and nonneuronal cells. The stimulation of the activity of this IRES in neuroblastoma cells provides a novel method by which N-Myc protein expression is upregulated in these cell types. It is therefore likely that translation initiation mediated by the N-myc IRES plays a contributory role in the high expression of N-Myc in neuroblastomas. Finally, we found the N-myc IRES to be considerably more active (between three-and sevenfold, depending on the cell line) than even the highly active EMCV IRES in all neuronal cell lines tested (data not shown). In this respect it could be of great value as a tool for expressing proteins in the central nervous system. This could be advantageous relative to viral IRESs that have already been tested for this purpose (Derrington et al., 1999) .
Materials and methods

Cell culture
All cell lines were grown at 378C in a humidi®ed atmosphere containing 5% CO 2 . The cell lines HeLa (human cervical epitheloid carcinoma), MCF7 (human breast carcinoma) and HEK293 (human embryonic kidney) were grown in Dulbecco's modi®ed Eagle's medium with Glutamax (Gibco BRL) supplemented with 10% foetal calf serum (Helena Biosciences). The cell lines SH-SY5Y (human neuroblastoma) and NT2 (neuronal precursor cells derived from a human teratocarcinoma) were grown in 50% DMEM and 50% Ham F12 (Gibco BRL), supplemented with 10% foetal calf serum and 2 mM L-glutamine. The cell line NB2a (murine neuroblastoma) was grown in DMEM supplemented with 5% foetal calf serum and 5% horse serum. MCF7 cells were a gift from Dr M MacFarlane (MRC-Human Toxicology Unit, Leicester, UK), NB2a cells were a gift from Dr WG McLean (University of Liverpool, UK) and NT2 cells were a gift from Dr K Young (University of Leicester, UK). All other cell lines were purchased from the American type culture collection.
Plasmid constructs
The plasmids pRF (formerly pGL3R2), pRMF (formerly pGL3R2utr) and phpRMF (formerly pGL3R2utrH) have been described previously (Stoneley et al., 1998) . A cDNA encoding the N-myc 5'UTR was obtained by RT-PCR of RNA extracted from SH-SY5Y cells using TRI Reagent (Sigma) and poly(A) + selected using oligo(dT) Dynabeads (Dynal). The oligonucleotides used were 5'-AAGAATTCGTCTGGACGCGCTGGGTGGATGCGGG-3' and 5'-TTTCCATGGTGGACGTGGAGCAGC-3'. The PCR product was inserted into pRF between the EcoRI and NcoI sites to create the vector pRNF. The DNA encoding the N-myc 5'UTR was excised from pRNF between the SpeI and NcoI sites and inserted into the vector phpRF between these sites to create the vector phpRNF.
The 5' deletion mutants 7234/1, 7164/1 and 779/1 were created by PCR using pRNF as a template and the reverse primer used to amplify the N-myc 5' UTR. The forward primers used were 5'-GCGGAATTCCTGTAGCCATCC-GAG-3', 5'-GCCGAATTCTCCCCTGCAGTCGGC-3' and 5'-CCCGAATTCAAAACGAACGGGGCG-3' respectively. The 3' deletion mutants 7320/774, 7320/7159 and 7320/7229 were created by PCR using pRNF as a template and the forward primer used to amplify the N-myc 5' UTR. The reverse primers used were 5'-GTTCCATGGAA-TACCGGGGGTGCT-3', 5'-TGCCCATGGTCCGGATTC-GATTCT-3' and 5'-TGGCCATGGTCTGTGCGCGCT-TGC-3' respectively. All PCR products were inserted into the vector pRF between the EcoRI and NcoI sites.
DNA transfections
All cells were transfected using FuGENE6 (Roche) according to the manufacturer's protocols.
Reporter gene analysis
The activity of both ®re¯y and Renilla luciferase in lysates prepared from transfected cells was measured using the Dual-luciferase reporter assay system (Promega), according to the manufacturer's instructions. The activity of bgalactosidase in lysates prepared from cells transfected with pcDNA3.1/HisB/lacZ was measured using the Galactolight plus assay system (Tropix). Light emission was measured over 10 s using an Opticomp-1 Luminometer (MGM instruments).
RNase protection
A DNA fragment was ampli®ed from pRNF using the primers 5'-GCAAGAAGATGCACCTGATG-3' and 5'-ATAAGCTTGCGTATCTCTTCATAGCCTT-3' and ligated into the plasmid pSK + Bluescript (Stratagene) between the EcoRV and HindIII sites so as to be in an antisense orientation relative to the T7 promoter. The resultant plasmid was linearized using NotI and used as a template to generate a 32 P-UTP (800 Ci/mmol) labelled riboprobe by run-o transcription using T7 RNA polymerase. RNase protection was then performed using poly(A) + mRNA from HeLa cells transfected with pRNF, poly(A) + mRNA from mock-transfected HeLa cells, and 10 mg tRNA as described previously (Stoneley et al., 1998) .
Differentiation of neuronal cells
Dierentiation was initiated in SH-SY5Y cells by the application of 4 mM retinoic acid (Sigma) for 24 h, and in Oncogene NB2a cells by the application of 1 mM dibutyryl cyclic AMP (Sigma) for 24 h. NT2 cells were treated with 10 mM retinoic acid three times weekly over a 5-week period to induce dierentiation to hNT neurons.
